 | • レポートコード：D0804-14919 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオマーカーテストの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオマーカーテストの種類別市場規模（がん、循環器、感染症、中枢神経系）、用途別市場規模（製薬・バイオテクノロジー企業、診断ツール企業、ヘルスケアIT /ビッグデータ企業、臨床検査室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：F. Hoffmann-La Roche、GlaxoSmithKline、Novartis、Quest Diagnostics、PFIZER、Medtronics、GE Healthcare ・地域別グローバル市場分析 2015年-2020年 ・バイオマーカーテストの北米市場（アメリカ、カナダ、メキシコ） ・バイオマーカーテストのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオマーカーテストのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオマーカーテストの南米市場（ブラジル、アルゼンチン） ・バイオマーカーテストの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：がん、循環器、感染症、中枢神経系 ・用途別分析：製薬・バイオテクノロジー企業、診断ツール企業、ヘルスケアIT /ビッグデータ企業、臨床検査室 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Biomarker Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biomarker Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biomarker Test market has been segmented into:
Cancer
Cardiovascular
Infectious Diseases
Central Nervous System
By Application, Biomarker Test has been segmented into:
Pharma & Biotech Companies
Diagnostic tool companies
Healthcare IT/Big data companies
Clinical laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biomarker Test market presented in the report. This section sheds light on the sales growth of different regional and country-level Biomarker Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biomarker Test market.
The report offers in-depth assessment of the growth and other aspects of the Biomarker Test market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biomarker Test Market Share Analysis
Biomarker Test competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biomarker Test sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biomarker Test sales, revenue and market share for each player covered in this report.
The major players covered in Biomarker Test are:
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Quest Diagnostics
PFIZER
Medtronics
GE Healthcare
Table of Contents
1 Biomarker Test Market Overview
1.1 Product Overview and Scope of Biomarker Test
1.2 Classification of Biomarker Test by Type
1.2.1 Global Biomarker Test Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biomarker Test Revenue Market Share by Type in 2019
1.2.3 Cancer
1.2.4 Cardiovascular
1.2.5 Infectious Diseases
1.2.6 Central Nervous System
1.3 Global Biomarker Test Market by Application
1.3.1 Overview: Global Biomarker Test Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharma & Biotech Companies
1.3.3 Diagnostic tool companies
1.3.4 Healthcare IT/Big data companies
1.3.5 Clinical laboratories
1.4 Global Biomarker Test Market by Regions
1.4.1 Global Biomarker Test Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biomarker Test (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biomarker Test Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biomarker Test Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biomarker Test Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biomarker Test Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biomarker Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 Quest Diagnostics
2.4.1 Quest Diagnostics Details
2.4.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Quest Diagnostics SWOT Analysis
2.4.4 Quest Diagnostics Product and Services
2.4.5 Quest Diagnostics Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 PFIZER
2.5.1 PFIZER Details
2.5.2 PFIZER Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 PFIZER SWOT Analysis
2.5.4 PFIZER Product and Services
2.5.5 PFIZER Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.6 Medtronics
2.6.1 Medtronics Details
2.6.2 Medtronics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Medtronics SWOT Analysis
2.6.4 Medtronics Product and Services
2.6.5 Medtronics Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GE Healthcare SWOT Analysis
2.7.4 GE Healthcare Product and Services
2.7.5 GE Healthcare Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biomarker Test Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biomarker Test Players Market Share
3.2.2 Top 10 Biomarker Test Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biomarker Test Revenue and Market Share by Regions
4.2 North America Biomarker Test Revenue and Growth Rate (2015-2020)
4.3 Europe Biomarker Test Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biomarker Test Revenue and Growth Rate (2015-2020)
4.5 South America Biomarker Test Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biomarker Test Revenue and Growth Rate (2015-2020)
5 North America Biomarker Test Revenue by Countries
5.1 North America Biomarker Test Revenue by Countries (2015-2020)
5.2 USA Biomarker Test Revenue and Growth Rate (2015-2020)
5.3 Canada Biomarker Test Revenue and Growth Rate (2015-2020)
5.4 Mexico Biomarker Test Revenue and Growth Rate (2015-2020)
6 Europe Biomarker Test Revenue by Countries
6.1 Europe Biomarker Test Revenue by Countries (2015-2020)
6.2 Germany Biomarker Test Revenue and Growth Rate (2015-2020)
6.3 UK Biomarker Test Revenue and Growth Rate (2015-2020)
6.4 France Biomarker Test Revenue and Growth Rate (2015-2020)
6.5 Russia Biomarker Test Revenue and Growth Rate (2015-2020)
6.6 Italy Biomarker Test Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biomarker Test Revenue by Countries
7.1 Asia-Pacific Biomarker Test Revenue by Countries (2015-2020)
7.2 China Biomarker Test Revenue and Growth Rate (2015-2020)
7.3 Japan Biomarker Test Revenue and Growth Rate (2015-2020)
7.4 Korea Biomarker Test Revenue and Growth Rate (2015-2020)
7.5 India Biomarker Test Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biomarker Test Revenue and Growth Rate (2015-2020)
8 South America Biomarker Test Revenue by Countries
8.1 South America Biomarker Test Revenue by Countries (2015-2020)
8.2 Brazil Biomarker Test Revenue and Growth Rate (2015-2020)
8.3 Argentina Biomarker Test Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biomarker Test by Countries
9.1 Middle East & Africa Biomarker Test Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biomarker Test Revenue and Growth Rate (2015-2020)
9.3 UAE Biomarker Test Revenue and Growth Rate (2015-2020)
9.4 Egypt Biomarker Test Revenue and Growth Rate (2015-2020)
9.5 South Africa Biomarker Test Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biomarker Test Revenue and Market Share by Type (2015-2020)
10.2 Global Biomarker Test Market Forecast by Type (2019-2024)
10.3 Cancer Revenue Growth Rate (2015-2025)
10.4 Cardiovascular Revenue Growth Rate (2015-2025)
10.5 Infectious Diseases Revenue Growth Rate (2015-2025)
10.6 Central Nervous System Revenue Growth Rate (2015-2025)
11 Global Biomarker Test Market Segment by Application
11.1 Global Biomarker Test Revenue Market Share by Application (2015-2020)
11.2 Biomarker Test Market Forecast by Application (2019-2024)
11.3 Pharma & Biotech Companies Revenue Growth (2015-2020)
11.4 Diagnostic tool companies Revenue Growth (2015-2020)
11.5 Healthcare IT/Big data companies Revenue Growth (2015-2020)
11.6 Clinical laboratories Revenue Growth (2015-2020)
12 Global Biomarker Test Market Size Forecast (2021-2025)
12.1 Global Biomarker Test Market Size Forecast (2021-2025)
12.2 Global Biomarker Test Market Forecast by Regions (2021-2025)
12.3 North America Biomarker Test Revenue Market Forecast (2021-2025)
12.4 Europe Biomarker Test Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biomarker Test Revenue Market Forecast (2021-2025)
12.6 South America Biomarker Test Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biomarker Test Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biomarker Test Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biomarker Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biomarker Test Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biomarker Test Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 6. F. Hoffmann-La Roche Biomarker Test Major Business
Table 7. F. Hoffmann-La Roche Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 8. F. Hoffmann-La Roche SWOT Analysis
Table 9. F. Hoffmann-La Roche Biomarker Test Product and Solutions
Table 10. F. Hoffmann-La Roche Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Biomarker Test Major Business
Table 13. GlaxoSmithKline Biomarker Test Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Biomarker Test Product and Solutions
Table 16. GlaxoSmithKline Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Biomarker Test Major Business
Table 19. Novartis Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Biomarker Test Product and Solutions
Table 22. Novartis Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Quest Diagnostics Corporate Information, Location and Competitors
Table 24. Quest Diagnostics Biomarker Test Major Business
Table 25. Quest Diagnostics Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 26. Quest Diagnostics SWOT Analysis
Table 27. Quest Diagnostics Biomarker Test Product and Solutions
Table 28. Quest Diagnostics Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. PFIZER Corporate Information, Location and Competitors
Table 30. PFIZER Biomarker Test Major Business
Table 31. PFIZER Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 32. PFIZER SWOT Analysis
Table 33. PFIZER Biomarker Test Product and Solutions
Table 34. PFIZER Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Medtronics Corporate Information, Location and Competitors
Table 36. Medtronics Biomarker Test Major Business
Table 37. Medtronics Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 38. Medtronics SWOT Analysis
Table 39. Medtronics Biomarker Test Product and Solutions
Table 40. Medtronics Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. GE Healthcare Corporate Information, Location and Competitors
Table 42. GE Healthcare Biomarker Test Major Business
Table 43. GE Healthcare Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 44. GE Healthcare SWOT Analysis
Table 45. GE Healthcare Biomarker Test Product and Solutions
Table 46. GE Healthcare Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Biomarker Test Revenue (Million USD) by Players (2015-2020)
Table 48. Global Biomarker Test Revenue Share by Players (2015-2020)
Table 49. Global Biomarker Test Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Biomarker Test Revenue Market Share by Regions (2015-2020)
Table 51. North America Biomarker Test Revenue by Countries (2015-2020)
Table 52. North America Biomarker Test Revenue Market Share by Countries (2015-2020)
Table 53. Europe Biomarker Test Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Biomarker Test Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Biomarker Test Revenue by Countries (2015-2020)
Table 56. South America Biomarker Test Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Biomarker Test Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Biomarker Test Revenue Market Share by Countries (2015-2020)
Table 59. Global Biomarker Test Revenue (Million USD) by Type (2015-2020)
Table 60. Global Biomarker Test Revenue Share by Type (2015-2020)
Table 61. Global Biomarker Test Revenue Forecast by Type (2021-2025)
Table 62. Global Biomarker Test Revenue by Application (2015-2020)
Table 63. Global Biomarker Test Revenue Share by Application (2015-2020)
Table 64. Global Biomarker Test Revenue Forecast by Application (2021-2025)
Table 65. Global Biomarker Test Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biomarker Test Picture
Figure 2. Global Biomarker Test Revenue Market Share by Type in 2019
Figure 3. Cancer Picture
Figure 4. Cardiovascular Picture
Figure 5. Infectious Diseases Picture
Figure 6. Central Nervous System Picture
Figure 7. Biomarker Test Revenue Market Share by Application in 2019
Figure 8. Pharma & Biotech Companies Picture
Figure 9. Diagnostic tool companies Picture
Figure 10. Healthcare IT/Big data companies Picture
Figure 11. Clinical laboratories Picture
Figure 12. Global Biomarker Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Biomarker Test Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Biomarker Test Revenue Market Share in 2019
Figure 21. Global Top 10 Players Biomarker Test Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Biomarker Test Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Biomarker Test Revenue Market Share by Regions (2015-2020)
Figure 25. Global Biomarker Test Revenue Market Share by Regions in 2018
Figure 26. North America Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 27. Europe Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 29. South America Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 31. North America Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 32. North America Biomarker Test Revenue Market Share by Countries in 2019
Figure 33. USA Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 34. Canada Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 36. Europe Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Biomarker Test Revenue Market Share by Countries in 2019
Figure 38. Germany Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 39. UK Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 40. France Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 41. Russia Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 42. Italy Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Biomarker Test Revenue Market Share by Countries in 2019
Figure 45. China Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 46. Japan Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 47. Korea Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 48. India Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 50. South America Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 51. South America Biomarker Test Revenue Market Share by Countries in 2019
Figure 52. Brazil Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Biomarker Test Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 57. UAE Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 60. Global Biomarker Test Revenue Share by Type (2015-2020)
Figure 61. Global Biomarker Test Revenue Share by Type in 2019
Figure 62. Global Biomarker Test Market Share Forecast by Type (2021-2025)
Figure 63. Global Cancer Revenue Growth Rate (2015-2020)
Figure 64. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 65. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 66. Global Central Nervous System Revenue Growth Rate (2015-2020)
Figure 67. Global Biomarker Test Revenue Share by Application (2015-2020)
Figure 68. Global Biomarker Test Revenue Share by Application in 2019
Figure 69. Global Biomarker Test Market Share Forecast by Application (2021-2025)
Figure 70. Global Pharma & Biotech Companies Revenue Growth Rate (2015-2020)
Figure 71. Global Diagnostic tool companies Revenue Growth Rate (2015-2020)
Figure 72. Global Healthcare IT/Big data companies Revenue Growth Rate (2015-2020)
Figure 73. Global Clinical laboratories Revenue Growth Rate (2015-2020)
Figure 74. Global Biomarker Test Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Biomarker Test Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Biomarker Test Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Biomarker Test Revenue Market Forecast (2021-2025)
Figure 78. Europe Biomarker Test Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Biomarker Test Revenue Market Forecast (2021-2025)
Figure 80. South America Biomarker Test Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Biomarker Test Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
デジタルバイオマーカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Digital Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Digital Biomarker market re…- 循環バイオマーカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Circulating Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circulating Biomarker m…
- バイオマーカー検出システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Biomarker Detection Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 診断用エキソソームバイオマーカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Diagnostic Exosome Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diagnostic Exoso…
- がん検査キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Test Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Test Kits market repo…